Cargando…

Pregnancy outcome in Charcot–Marie–Tooth disease: results of the CMT‐NET cohort study in Germany

BACKGROUND AND PURPOSE: Systematic research on the effect of Charcot–Marie–Tooth (CMT) disease on the outcome of pregnancy and conversely the effect of pregnancy on neuropathy is still sparse. METHODS: A clinical cohort study and cross‐sectional study within the German CMT‐NET was conducted between...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rudnik‐Schöneborn, S., Thiele, S., Walter, M. C., Reinecke, L., Sereda, M., Schöneborn, R., Elbracht, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Neuropathies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496596/ https://www.ncbi.nlm.nih.gov/pubmed/32400062 http://dx.doi.org/10.1111/ene.14317

Ejemplares similares

Frequency, entity and determinants of fatigue in Charcot–Marie–Tooth disease
por: Bellofatto, Marta, et al.
Publicado: (2022)

Mutations in MYO9B are associated with Charcot–Marie–Tooth disease type 2 neuropathies and isolated optic atrophy
por: Cipriani, Silvia, et al.
Publicado: (2022)

Early data on long‐term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2‐year update from the open‐label extension of the NEURO‐TTR trial
por: Brannagan, T. H., et al.
Publicado: (2020)

Genetics of Charcot-Marie-Tooth (CMT) Disease within the Frame of the Human Genome Project Success
por: Timmerman, Vincent, et al.
Publicado: (2014)

Unmasking a Case of Asymptomatic Charcot-Marie-Tooth Disease (CMT1A) With Vincristine
por: Jariwal, Roopam, et al.
Publicado: (2018)

Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry
por: Bellofatto, Marta, et al.
Publicado: (2022)

Pathogenic Mechanism of the FIG4 Mutation Responsible for Charcot-Marie-Tooth Disease CMT4J
por: Lenk, Guy M., et al.
Publicado: (2011)

Guillain‐Barré syndrome in a patient with antibodies against SARS‐COV‐2
por: Helbok, R., et al.
Publicado: (2020)

Cardiovascular health and chronic axonal polyneuropathy: A population‐based study
por: Taams, Noor E., et al.
Publicado: (2021)

Association of plasma neurofilament light chain with disease activity in chronic inflammatory demyelinating polyradiculoneuropathy
por: Kapoor, Mahima, et al.
Publicado: (2022)

Primary Sjögren syndrome‐related peripheral neuropathy: A systematic review and meta‐analysis
por: Liampas, Andreas, et al.
Publicado: (2022)

Corneal nerve loss is related to the severity of painful diabetic neuropathy
por: Kalteniece, Alise, et al.
Publicado: (2021)

Validation of motor and functional scales for the evaluation of adult patients with 5q spinal muscular atrophy
por: Vázquez‐Costa, Juan F., et al.
Publicado: (2022)

Accelerate Clinical Trials in Charcot-Marie-Tooth Disease (ACT-CMT): A Protocol to Address Clinical Trial Readiness in CMT1A
por: Eichinger, Katy, et al.
Publicado: (2022)

Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial
por: Pareyson, Davide, et al.
Publicado: (2011)

Cerebrospinal fluid protein in Guillain–Barré syndrome: Need for age‐dependent interpretation
por: Hegen, Harald, et al.
Publicado: (2020)

Randomized trial of intravenous immunoglobulin maintenance treatment regimens in chronic inflammatory demyelinating polyradiculoneuropathy
por: Kuitwaard, K., et al.
Publicado: (2020)

Contribution of sleep disturbances to fatigue in multiple sclerosis: a prospective study using clinical and polysomnographic parameters
por: Riccitelli, Gianna C., et al.
Publicado: (2021)

Dolichoarteriopathies of the extracranial internal carotid artery: The Plaque At RISK study
por: Dilba, Kristine, et al.
Publicado: (2021)

Quantitative magnetic resonance imaging of the brachial plexus shows specific changes in nerve architecture in chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy and motor neuron disease
por: van Rosmalen, Marieke H. J., et al.
Publicado: (2021)

Very early and early neurophysiological abnormalities in Guillain–Barré syndrome: A 4‐year retrospective study
por: Rasera, Andrea, et al.
Publicado: (2021)

Misdiagnosis and diagnostic pitfalls of chronic inflammatory demyelinating polyradiculoneuropathy
por: Broers, Merel C., et al.
Publicado: (2021)

Genetic biomarkers for intravenous immunoglobulin response in chronic inflammatory demyelinating polyradiculoneuropathy
por: Kuitwaard, Krista, et al.
Publicado: (2021)

Neurofilament light chain and total tau in the differential diagnosis and prognostic evaluation of acute and chronic inflammatory polyneuropathies
por: Kmezic, Ivan, et al.
Publicado: (2022)

Acute flaccid myelitis and Guillain–Barré syndrome in children: A comparative study with evaluation of diagnostic criteria
por: Helfferich, Jelte, et al.
Publicado: (2021)

Real‐life experience with inotersen in hereditary transthyretin amyloidosis with late‐onset phenotype: Data from an early‐access program in Italy
por: Luigetti, Marco, et al.
Publicado: (2022)

Genetic evidence for the most common risk factors for chronic axonal polyneuropathy in the general population
por: Taams, Noor E., et al.
Publicado: (2022)

Guillain–Barré syndrome following influenza vaccination: A 15‐year nationwide population‐based case–control study
por: Levison, Lotte Sahin, et al.
Publicado: (2022)

Ictal apnea: A prospective monocentric study in patients with epilepsy
por: Micalizzi, Elisa, et al.
Publicado: (2022)

Electroencephalography functional connectivity—A biomarker for painful polyneuropathy
por: Topaz, Leah Shafran, et al.
Publicado: (2022)

Hindsight for ultrasound imaging/measurement of the tibial nerve (answer)
por: Dhanapalaratnam, Roshan, et al.
Publicado: (2022)

A diagnostic score for anti‐myelin‐associated‐glycoprotein neuropathy or chronic inflammatory demyelinating polyradiculoneuropathy in patients with anti‐myelin‐associated‐glycoprotein antibody
por: Doneddu, Pietro E., et al.
Publicado: (2022)

Charcot-Marie-Tooth neuropathy score and ambulation index are both predictors of orthotic need for patients with CMT
por: Prada, Valeria, et al.
Publicado: (2021)

Charcot Marie Tooth disease (CMT4A) due to GDAP1 mutation: report of a Colombian family
por: Martin, Angela M, et al.
Publicado: (2015)

Diagnostic laboratory testing for Charcot Marie Tooth disease (CMT): the spectrum of gene defects in Norwegian patients with CMT and its implications for future genetic test strategies
por: Østern, Rune, et al.
Publicado: (2013)

MFN2 point mutations occur in 3.4% of Charcot-Marie-Tooth families. An investigation of 232 Norwegian CMT families
por: Braathen, Geir J, et al.
Publicado: (2010)

Diagnosis of Charcot-Marie-Tooth Disease
por: Banchs, Isabel, et al.
Publicado: (2009)

Pregnancy and delivery in patients with Charcot-Marie-Tooth disease and related disorders
por: Skorupinska, Mariola, et al.
Publicado: (2022)

Genetic tests in sports medicine - many studies, little impact
por: Rudnik-Schöneborn, Sabine
Publicado: (2012)

Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A)
por: Prukop, Thomas, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0v2tqu3kl856n8ghc6ig2hco5b